Related Experiment Video

Updated: May 5, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

7.5K

Corrigendum: Development of new approach methods for the identification and characterization of endocrine metabolic

Albert Braeuning1, Patrick Balaguer2, William Bourguet3

  • 1Department of Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany.

Frontiers in Toxicology
|April 9, 2024
PubMed

Keywords:
adipocytesendocrine metabolic disruptionenergy metabolismlivernuclear receptorsobesogens

More Related Videos

Methods to Test Endocrine Disruption in Drosophila melanogaster09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

9.7K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.9K

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K